Photobiomodulation Therapy for Dementia: A Systematic Review of Pre-Clinical and Clinical Studies
- 12 October 2021
- journal article
- review article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 83 (4) , 1431-1452
Abstract
Background: Photobiomodulation (PBM) involves the use of red and/or near-infrared light from lasers or LEDs to improve a wide range of medical disorders. Transcranial PBM, sometimes accompanied by intranasal PBM, has been tested to improve many brain disorders, including dementia. Objective: To conduct a systematic review according to PRISMA guidelines of pre-clinical and clinical studies reporting the use of PBM, which were considered relevant to dementia. Methods: Literature was searched between 1967 and 2020 using a range of keywords relevant to PBM and dementia. The light source and wavelength(s), output power, irradiance, irradiation time, fluence or total energy (dose), operation mode (continuous or pulsed) irradiation, approach and site, number of treatment sessions, as well as study outcome(s) were extracted. Results: Out of 10,473 initial articles, 36 studies met the inclusion criteria. Nine articles reported in vitro studies, 17 articles reported studies in animal models of dementia, and 10 studies were conducted in dementia patients. All of the included studies reported positive results. The clinical studies were limited by the small number of patients, lack of placebo controls in some instances, and only a few used objective neuroimaging methods. Conclusion: The preliminary evidence of clinical benefit, the lack of any adverse effects, and the remarkable ease of use, suggest larger clinical trials should be conducted as soon as possible.Keywords
This publication has 105 references indexed in Scilit:
- The Nuts and Bolts of Low-level Laser (Light) TherapyAnnals of Biomedical Engineering, 2011
- Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's diseaseBrain Research, 2011
- Relationships between Beta-Amyloid and Functional Connectivity in Different Components of the Default Mode Network in AgingCerebral Cortex, 2011
- Low energy laser light (632.8 nm) suppresses amyloid-β peptide-induced oxidative and inflammatory responses in astrocytesNeuroscience, 2010
- Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trialsThe Lancet, 2009
- Low infra red laser light irradiation on cultured neural cells: effects on mitochondria and cell viability after oxidative stressBMC Complementary and Alternative Medicine, 2009
- Mild Cognitive Impairment and Alzheimer Disease: Patterns of Altered Cerebral Blood Flow at MR ImagingRadiology, 2009
- Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxietyBehavioral and Brain Functions, 2009
- Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicityNeuroscience, 2008
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991